Evidence map›Paper›PMID 20644254›Full record

ArticleThe Journal of clinical investigation2010

Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation.

Hongxia Z Imtiyaz, Emily P Williams, Michele M Hickey, Shetal A Patel, Amy C Durham, Li-Jun Yuan, Rachel Hammond, Phyllis A Gimotty, Brian Keith, M Celeste Simon

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 300 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
300citing papers in PubMed, 1 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

300 citing papers in PubMed, 1 synthesis or guideline pooled it, 446 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

240 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 4 countries.

Hongxia Z ImtiyazAbramson Family Cancer Research Institute, Howard Hughes Medical Institute, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6160, USA
Emily P Williams
Michele M Hickey
Shetal A Patel
Amy C Durham
Li-Jun Yuan
Rachel Hammond
Phyllis A Gimotty
Brian Keith
M Celeste Simon
Cancer Research Institute · USUniversity of Veterinary Medicine · HU

Funding

Howard Hughes Medical InstitutePHS HHS 66310
6 · The paper itself

Abstract

Hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha display unique and sometimes opposing activities in regulating cellular energy homeostasis, cell fate decisions, and oncogenesis. Macrophages exposed to hypoxia accumulate both HIF-1alpha and HIF-2alpha, and overexpression of HIF-2alpha in tumor-associated macrophages (TAMs) is specifically correlated with high-grade human tumors and poor prognosis. However, the precise role of HIF-2alpha during macrophage-mediated inflammatory responses remains unclear. To fully characterize cellular hypoxic adaptations, distinct functions of HIF-1alpha versus HIF-2alpha must be elucidated. We demonstrate here that mice lacking HIF-2alpha in myeloid cells (Hif2aDelta/Delta mice) are resistant to lipopolysaccharide-induced endotoxemia and display a marked inability to mount inflammatory responses to cutaneous and peritoneal irritants. Furthermore, HIF-2alpha directly regulated proinflammatory cytokine/chemokine expression in macrophages activated in vitro. Hif2aDelta/Delta mice displayed reduced TAM infiltration in independent murine hepatocellular and colitis-associated colon carcinoma models, and this was associated with reduced tumor cell proliferation and progression. Notably, HIF-2alpha modulated macrophage migration by regulating the expression of the cytokine receptor M-CSFR and the chemokine receptor CXCR4, without altering intracellular ATP levels. Collectively, our data identify HIF-2alpha as an important regulator of innate immunity, suggesting it may be a useful therapeutic target for treating inflammatory disorders and cancer.

Indexed as

Acute DiseaseAnimalsBasic Helix-Loop-Helix ProteinsCell MovementCytokinesDisease Models, AnimalEndothelial PAS Domain-Containing Protein 1EndotoxemiaFemaleImmunity, InnateInflammationLipopolysaccharidesMacrophagesMiceMice, Inbred C57BLNeoplasmsBasic Helix-Loop-Helix ProteinsCXCR4 protein, mouseCytokinesEndothelial PAS Domain-Containing Protein 1LipopolysaccharidesNitric OxideReceptors, CXCR4

Identifiers

PMID20644254
PMCPMC2912179
OpenAlexW2041418689

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.